U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323914) titled 'Clinical Analgesic Management in Dementia' on Dec. 23, 2025.
Brief Summary: This study is designed to assess the efficacy and safety of oxycodone in managing moderate to severe pain in patients with Alzheimer's disease. The trial will be conducted at Xuanwu Hospital, Capital Medical University, and will enroll 10 eligible participants. Participants will receive oxycodone/acetaminophen (5 mg/325 mg) once daily for 12 weeks. The treatment will follow international guidelines, with dosages adjusted based on the patient's baseline pain levels and individual needs. Dosages will be adjusted based on baseline pain levels and patient needs, ...